动态生物网
发布采购单
动态生物网QQ群
当前位置: 首页 » 品牌展 » - B - »

beacle

品牌展介绍
Beacle Inc. was founded in 2002 by professors of four universities (Osaka, Keio, Kobe, and Okayama) in order to industrialize Bionanocapsule which was co-invented by them.
Bionanocapsule(BNC)is a hollow nano-sized particle that is produced by expressing HBV’s surface protein in yeast. BNC, being similar to the envelop of HBV in structure and function, can be utilized for various purposes.
based on the BNC technology, we develops drug delivery system (DDS) by using BNC’s cellular delivery ability, highly sensitive Multi-Antibody Detection (MAD) system by using BNC consisted of antibody-binding proteins, new types of HBV vaccine by using BNC expressing the surface antigen identical to natural HBV. We also develop research reagents products for HBV- and Immunoassay-related fields.
Our motto is the development of technologies and products with highly originality, and we continue to pay our effort for development. Please watch our next invention.

Beacle, Inc. 以工业化制造 "Bio-nanocapsule" 著名,目前与日本多所大学合作进行实验与研究。Bio-nanocapsule (BNC) 本质为中空的纳米级微粒,其上具有利用基因转殖酵母菌生产之B型肝炎表面抗原─L-protein,此抗原可专一性辨识人类肝细胞,并借此将内涵物送入目标细胞质内,是具有极大发展潜力之药物制放系统 (drug delivery system, DDS)。Beacle, Inc. 仍在积极开发多样化BNC作为其他种类细胞之药物制放系统。
联系方式/代理商
14‐1, Yoshida Kawaracho, Sakyo-ku Kyoto-shi, Kyoto, 606-8305, Japan
TEL 075-762-5055
FAX 075-762-3055
MAIL: binformation@beacle.com
 
[ 品牌展搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 违规举报 ]  [ 关闭窗口 ]

0条 [查看全部]  相关评论

 
最新品牌展
动态生物网
产品检索: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
(C)2016 动态生物网 | Processed in 1,524,749,012.715 second(s), 9 queries, Memory 0.93 M